カテゴリー： GlobalInfoResearch, 世界, 医療/バイオ

世界のバンコマイシン市場2022年：ダプトマイシン、リネゾリド、キヌプリスチン、アンピシリン、クロラムフェニコール、その他

◆英語タイトル：Global Vancomycin Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
	◆商品コード：GIR22MY8983 ◆発行会社（リサーチ会社）：GlobalInfoResearch ◆発行日：2022年5月（※2025年版があります。お問い合わせください。） ◆ページ数：122 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（注文後2-3日） ◆調査対象地域：グローバル ◆産業分野：医薬品

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,480 ⇒換算￥528,960	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD5,220 ⇒換算￥793,440	見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）	USD6,960 ⇒換算￥1,057,920	見積依頼/購入/質問フォーム

★GlobalInfoResearchに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

バンコマイシン市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界のバンコマイシンの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

バンコマイシン市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・ダプトマイシン、リネゾリド、キヌプリスチン、アンピシリン、クロラムフェニコール、その他

用途別セグメントは次のように区分されます。
・敗血症、肺感染症、皮膚軟部組織感染症、大腸炎＆腸炎症、感染症予防

世界のバンコマイシン市場の主要な市場プレーヤーは以下のとおりです。
・Pfizer、Eli Lilly and Company、CJ CheilJedang、Xellia Pharmaceuticals ApS、VIANEX、Alchemia Limited、Alvogen、Aphios Corporation、Cellceutix Corporation、Enanta Pharmaceuticals、Helix BioMedix、LegoChem Biosciences、Lytix Biopharma、MGB Biopharma Limited、Microbiotix.、MicuRx Pharmaceuticals、Nabriva Therapeutics、NovaBay Pharmaceuticals、NovoBiotic Pharmaceuticals、Oragenics、Sealife Pharma、Taiwan Zhengde Pharmaceutical、Zhejiang Pharmaceutical、Zhejiang Haizheng Pharmaceutical、North China Pharmaceutical、Shenwei Pharmaceutical

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、バンコマイシン製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なバンコマイシンメーカーの企業概要、2019年～2022年までのバンコマイシンの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なバンコマイシンメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別バンコマイシンの販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までのバンコマイシンの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのバンコマイシン市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、およびバンコマイシンの産業チェーンを掲載しています。
・第13、14、15章では、バンコマイシンの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
・メーカー情報（企業概要、製品概要、販売量、価格、売上）：Pfizer、Eli Lilly and Company、CJ CheilJedang、Xellia Pharmaceuticals ApS、VIANEX、Alchemia Limited、Alvogen、Aphios Corporation、Cellceutix Corporation、Enanta Pharmaceuticals、Helix BioMedix、LegoChem Biosciences、Lytix Biopharma、MGB Biopharma Limited、Microbiotix.、MicuRx Pharmaceuticals、Nabriva Therapeutics、NovaBay Pharmaceuticals、NovoBiotic Pharmaceuticals、Oragenics、Sealife Pharma、Taiwan Zhengde Pharmaceutical、Zhejiang Pharmaceutical、Zhejiang Haizheng Pharmaceutical、North China Pharmaceutical、Shenwei Pharmaceutical
・メーカー別市場シェア
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：ダプトマイシン、リネゾリド、キヌプリスチン、アンピシリン、クロラムフェニコール、その他
・用途別分析2017年-2028年：敗血症、肺感染症、皮膚軟部組織感染症、大腸炎＆腸炎症、感染症予防
・バンコマイシンの北米市場規模2017年-2028年：アメリカ、カナダ、メキシコ
・バンコマイシンのヨーロッパ市場規模2017年-2028年：ドイツ、イギリス、フランス、ロシア、イタリア
・バンコマイシンのアジア市場規模2017年-2028年：中国、日本、韓国、インド、東南アジア、オーストラリア
・バンコマイシンの南米市場規模2017年-2028年：ブラジル、アルゼンチン
・バンコマイシンの中東・アフリカ市場規模2017年-2028年：サウジアラビア、トルコ、エジプト、南アフリカ
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Vancomycin market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Vancomycin market size is estimated to be worth US$ 343.6 million in 2021 and is forecast to a readjusted size of USD 479.1 million by 2028 with a CAGR of 4.9% during review period. Sepsis accounting for % of the Vancomycin global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Daptomycin segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Vancomycin include Pfizer, Eli Lilly and Company, CJ CheilJedang, Xellia Pharmaceuticals ApS, and VIANEX, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Vancomycin market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Daptomycin
Linezolid
Quinupristin
Ampicillin
Chloramphenicol
Others
Market segment by Application can be divided into
Sepsis
Lung Infection
Skin Soft Tissue Infection
Colitis & Intestinal Inflammation
To Prevent Infection
The key market players for global Vancomycin market are listed below:
Pfizer
Eli Lilly and Company
CJ CheilJedang
Xellia Pharmaceuticals ApS
VIANEX
Alchemia Limited
Alvogen
Aphios Corporation
Cellceutix Corporation
Enanta Pharmaceuticals
Helix BioMedix
LegoChem Biosciences
Lytix Biopharma
MGB Biopharma Limited
Microbiotix.
MicuRx Pharmaceuticals
Nabriva Therapeutics
NovaBay Pharmaceuticals
NovoBiotic Pharmaceuticals
Oragenics
Sealife Pharma
Taiwan Zhengde Pharmaceutical
Zhejiang Pharmaceutical
Zhejiang Haizheng Pharmaceutical
North China Pharmaceutical
Shenwei Pharmaceutical
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Vancomycin product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Vancomycin, with price, sales, revenue and global market share of Vancomycin from 2019 to 2022.
Chapter 3, the Vancomycin competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Vancomycin breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Vancomycin market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Vancomycin.
Chapter 13, 14, and 15, to describe Vancomycin sales channel, distributors, customers, research findings and conclusion, appendix and data source.

❖ レポートの目次 ❖

1 Market Overview
1.1 Vancomycin Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Vancomycin Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Daptomycin
1.2.3 Linezolid
1.2.4 Quinupristin
1.2.5 Ampicillin
1.2.6 Chloramphenicol
1.2.7 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Vancomycin Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Sepsis
1.3.3 Lung Infection
1.3.4 Skin Soft Tissue Infection
1.3.5 Colitis & Intestinal Inflammation
1.3.6 To Prevent Infection
1.4 Global Vancomycin Market Size & Forecast
1.4.1 Global Vancomycin Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Vancomycin Sales in Volume (2017-2028)
1.4.3 Global Vancomycin Price (2017-2028)
1.5 Global Vancomycin Production Capacity Analysis
1.5.1 Global Vancomycin Total Production Capacity (2017-2028)
1.5.2 Global Vancomycin Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Vancomycin Market Drivers
1.6.2 Vancomycin Market Restraints
1.6.3 Vancomycin Trends Analysis
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business
2.1.3 Pfizer Vancomycin Product and Services
2.1.4 Pfizer Vancomycin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Eli Lilly and Company
2.2.1 Eli Lilly and Company Details
2.2.2 Eli Lilly and Company Major Business
2.2.3 Eli Lilly and Company Vancomycin Product and Services
2.2.4 Eli Lilly and Company Vancomycin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 CJ CheilJedang
2.3.1 CJ CheilJedang Details
2.3.2 CJ CheilJedang Major Business
2.3.3 CJ CheilJedang Vancomycin Product and Services
2.3.4 CJ CheilJedang Vancomycin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Xellia Pharmaceuticals ApS
2.4.1 Xellia Pharmaceuticals ApS Details
2.4.2 Xellia Pharmaceuticals ApS Major Business
2.4.3 Xellia Pharmaceuticals ApS Vancomycin Product and Services
2.4.4 Xellia Pharmaceuticals ApS Vancomycin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 VIANEX
2.5.1 VIANEX Details
2.5.2 VIANEX Major Business
2.5.3 VIANEX Vancomycin Product and Services
2.5.4 VIANEX Vancomycin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Alchemia Limited
2.6.1 Alchemia Limited Details
2.6.2 Alchemia Limited Major Business
2.6.3 Alchemia Limited Vancomycin Product and Services
2.6.4 Alchemia Limited Vancomycin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Alvogen
2.7.1 Alvogen Details
2.7.2 Alvogen Major Business
2.7.3 Alvogen Vancomycin Product and Services
2.7.4 Alvogen Vancomycin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Aphios Corporation
2.8.1 Aphios Corporation Details
2.8.2 Aphios Corporation Major Business
2.8.3 Aphios Corporation Vancomycin Product and Services
2.8.4 Aphios Corporation Vancomycin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Cellceutix Corporation
2.9.1 Cellceutix Corporation Details
2.9.2 Cellceutix Corporation Major Business
2.9.3 Cellceutix Corporation Vancomycin Product and Services
2.9.4 Cellceutix Corporation Vancomycin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Enanta Pharmaceuticals
2.10.1 Enanta Pharmaceuticals Details
2.10.2 Enanta Pharmaceuticals Major Business
2.10.3 Enanta Pharmaceuticals Vancomycin Product and Services
2.10.4 Enanta Pharmaceuticals Vancomycin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Helix BioMedix
2.11.1 Helix BioMedix Details
2.11.2 Helix BioMedix Major Business
2.11.3 Helix BioMedix Vancomycin Product and Services
2.11.4 Helix BioMedix Vancomycin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 LegoChem Biosciences
2.12.1 LegoChem Biosciences Details
2.12.2 LegoChem Biosciences Major Business
2.12.3 LegoChem Biosciences Vancomycin Product and Services
2.12.4 LegoChem Biosciences Vancomycin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Lytix Biopharma
2.13.1 Lytix Biopharma Details
2.13.2 Lytix Biopharma Major Business
2.13.3 Lytix Biopharma Vancomycin Product and Services
2.13.4 Lytix Biopharma Vancomycin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 MGB Biopharma Limited
2.14.1 MGB Biopharma Limited Details
2.14.2 MGB Biopharma Limited Major Business
2.14.3 MGB Biopharma Limited Vancomycin Product and Services
2.14.4 MGB Biopharma Limited Vancomycin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15 Microbiotix.
2.15.1 Microbiotix. Details
2.15.2 Microbiotix. Major Business
2.15.3 Microbiotix. Vancomycin Product and Services
2.15.4 Microbiotix. Vancomycin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16 MicuRx Pharmaceuticals
2.16.1 MicuRx Pharmaceuticals Details
2.16.2 MicuRx Pharmaceuticals Major Business
2.16.3 MicuRx Pharmaceuticals Vancomycin Product and Services
2.16.4 MicuRx Pharmaceuticals Vancomycin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.17 Nabriva Therapeutics
2.17.1 Nabriva Therapeutics Details
2.17.2 Nabriva Therapeutics Major Business
2.17.3 Nabriva Therapeutics Vancomycin Product and Services
2.17.4 Nabriva Therapeutics Vancomycin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.18 NovaBay Pharmaceuticals
2.18.1 NovaBay Pharmaceuticals Details
2.18.2 NovaBay Pharmaceuticals Major Business
2.18.3 NovaBay Pharmaceuticals Vancomycin Product and Services
2.18.4 NovaBay Pharmaceuticals Vancomycin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.19 NovoBiotic Pharmaceuticals
2.19.1 NovoBiotic Pharmaceuticals Details
2.19.2 NovoBiotic Pharmaceuticals Major Business
2.19.3 NovoBiotic Pharmaceuticals Vancomycin Product and Services
2.19.4 NovoBiotic Pharmaceuticals Vancomycin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.20 Oragenics
2.20.1 Oragenics Details
2.20.2 Oragenics Major Business
2.20.3 Oragenics Vancomycin Product and Services
2.20.4 Oragenics Vancomycin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.21 Sealife Pharma
2.21.1 Sealife Pharma Details
2.21.2 Sealife Pharma Major Business
2.21.3 Sealife Pharma Vancomycin Product and Services
2.21.4 Sealife Pharma Vancomycin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.22 Taiwan Zhengde Pharmaceutical
2.22.1 Taiwan Zhengde Pharmaceutical Details
2.22.2 Taiwan Zhengde Pharmaceutical Major Business
2.22.3 Taiwan Zhengde Pharmaceutical Vancomycin Product and Services
2.22.4 Taiwan Zhengde Pharmaceutical Vancomycin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.23 Zhejiang Pharmaceutical
2.23.1 Zhejiang Pharmaceutical Details
2.23.2 Zhejiang Pharmaceutical Major Business
2.23.3 Zhejiang Pharmaceutical Vancomycin Product and Services
2.23.4 Zhejiang Pharmaceutical Vancomycin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.24 Zhejiang Haizheng Pharmaceutical
2.24.1 Zhejiang Haizheng Pharmaceutical Details
2.24.2 Zhejiang Haizheng Pharmaceutical Major Business
2.24.3 Zhejiang Haizheng Pharmaceutical Vancomycin Product and Services
2.24.4 Zhejiang Haizheng Pharmaceutical Vancomycin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.25 North China Pharmaceutical
2.25.1 North China Pharmaceutical Details
2.25.2 North China Pharmaceutical Major Business
2.25.3 North China Pharmaceutical Vancomycin Product and Services
2.25.4 North China Pharmaceutical Vancomycin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.26 Shenwei Pharmaceutical
2.26.1 Shenwei Pharmaceutical Details
2.26.2 Shenwei Pharmaceutical Major Business
2.26.3 Shenwei Pharmaceutical Vancomycin Product and Services
2.26.4 Shenwei Pharmaceutical Vancomycin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Vancomycin Breakdown Data by Manufacturer
3.1 Global Vancomycin Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Vancomycin Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Vancomycin
3.4 Market Concentration Rate
3.4.1 Top 3 Vancomycin Manufacturer Market Share in 2021
3.4.2 Top 6 Vancomycin Manufacturer Market Share in 2021
3.5 Global Vancomycin Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Vancomycin Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Vancomycin Market Size by Region
4.1.1 Global Vancomycin Sales in Volume by Region (2017-2028)
4.1.2 Global Vancomycin Revenue by Region (2017-2028)
4.2 North America Vancomycin Revenue (2017-2028)
4.3 Europe Vancomycin Revenue (2017-2028)
4.4 Asia-Pacific Vancomycin Revenue (2017-2028)
4.5 South America Vancomycin Revenue (2017-2028)
4.6 Middle East and Africa Vancomycin Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Vancomycin Sales in Volume by Type (2017-2028)
5.2 Global Vancomycin Revenue by Type (2017-2028)
5.3 Global Vancomycin Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Vancomycin Sales in Volume by Application (2017-2028)
6.2 Global Vancomycin Revenue by Application (2017-2028)
6.3 Global Vancomycin Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Vancomycin Sales by Type (2017-2028)
7.2 North America Vancomycin Sales by Application (2017-2028)
7.3 North America Vancomycin Market Size by Country
7.3.1 North America Vancomycin Sales in Volume by Country (2017-2028)
7.3.2 North America Vancomycin Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Vancomycin Sales by Type (2017-2028)
8.2 Europe Vancomycin Sales by Application (2017-2028)
8.3 Europe Vancomycin Market Size by Country
8.3.1 Europe Vancomycin Sales in Volume by Country (2017-2028)
8.3.2 Europe Vancomycin Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Vancomycin Sales by Type (2017-2028)
9.2 Asia-Pacific Vancomycin Sales by Application (2017-2028)
9.3 Asia-Pacific Vancomycin Market Size by Region
9.3.1 Asia-Pacific Vancomycin Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Vancomycin Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Vancomycin Sales by Type (2017-2028)
10.2 South America Vancomycin Sales by Application (2017-2028)
10.3 South America Vancomycin Market Size by Country
10.3.1 South America Vancomycin Sales in Volume by Country (2017-2028)
10.3.2 South America Vancomycin Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Vancomycin Sales by Type (2017-2028)
11.2 Middle East & Africa Vancomycin Sales by Application (2017-2028)
11.3 Middle East & Africa Vancomycin Market Size by Country
11.3.1 Middle East & Africa Vancomycin Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Vancomycin Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Vancomycin and Key Manufacturers
12.2 Manufacturing Costs Percentage of Vancomycin
12.3 Vancomycin Production Process
12.4 Vancomycin Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Vancomycin Typical Distributors
13.3 Vancomycin Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Vancomycin Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Vancomycin Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Pfizer Basic Information, Manufacturing Base and Competitors
Table 4. Pfizer Major Business
Table 5. Pfizer Vancomycin Product and Services
Table 6. Pfizer Vancomycin Sales (KG), Price (US$/G), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Eli Lilly and Company Basic Information, Manufacturing Base and Competitors
Table 8. Eli Lilly and Company Major Business
Table 9. Eli Lilly and Company Vancomycin Product and Services
Table 10. Eli Lilly and Company Vancomycin Sales (KG), Price (US$/G), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. CJ CheilJedang Basic Information, Manufacturing Base and Competitors
Table 12. CJ CheilJedang Major Business
Table 13. CJ CheilJedang Vancomycin Product and Services
Table 14. CJ CheilJedang Vancomycin Sales (KG), Price (US$/G), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Xellia Pharmaceuticals ApS Basic Information, Manufacturing Base and Competitors
Table 16. Xellia Pharmaceuticals ApS Major Business
Table 17. Xellia Pharmaceuticals ApS Vancomycin Product and Services
Table 18. Xellia Pharmaceuticals ApS Vancomycin Sales (KG), Price (US$/G), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. VIANEX Basic Information, Manufacturing Base and Competitors
Table 20. VIANEX Major Business
Table 21. VIANEX Vancomycin Product and Services
Table 22. VIANEX Vancomycin Sales (KG), Price (US$/G), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Alchemia Limited Basic Information, Manufacturing Base and Competitors
Table 24. Alchemia Limited Major Business
Table 25. Alchemia Limited Vancomycin Product and Services
Table 26. Alchemia Limited Vancomycin Sales (KG), Price (US$/G), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Alvogen Basic Information, Manufacturing Base and Competitors
Table 28. Alvogen Major Business
Table 29. Alvogen Vancomycin Product and Services
Table 30. Alvogen Vancomycin Sales (KG), Price (US$/G), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Aphios Corporation Basic Information, Manufacturing Base and Competitors
Table 32. Aphios Corporation Major Business
Table 33. Aphios Corporation Vancomycin Product and Services
Table 34. Aphios Corporation Vancomycin Sales (KG), Price (US$/G), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Cellceutix Corporation Basic Information, Manufacturing Base and Competitors
Table 36. Cellceutix Corporation Major Business
Table 37. Cellceutix Corporation Vancomycin Product and Services
Table 38. Cellceutix Corporation Vancomycin Sales (KG), Price (US$/G), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Enanta Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 40. Enanta Pharmaceuticals Major Business
Table 41. Enanta Pharmaceuticals Vancomycin Product and Services
Table 42. Enanta Pharmaceuticals Vancomycin Sales (KG), Price (US$/G), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Helix BioMedix Basic Information, Manufacturing Base and Competitors
Table 44. Helix BioMedix Major Business
Table 45. Helix BioMedix Vancomycin Product and Services
Table 46. Helix BioMedix Vancomycin Sales (KG), Price (US$/G), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. LegoChem Biosciences Basic Information, Manufacturing Base and Competitors
Table 48. LegoChem Biosciences Major Business
Table 49. LegoChem Biosciences Vancomycin Product and Services
Table 50. LegoChem Biosciences Vancomycin Sales (KG), Price (US$/G), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. Lytix Biopharma Basic Information, Manufacturing Base and Competitors
Table 52. Lytix Biopharma Major Business
Table 53. Lytix Biopharma Vancomycin Product and Services
Table 54. Lytix Biopharma Vancomycin Sales (KG), Price (US$/G), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 55. MGB Biopharma Limited Basic Information, Manufacturing Base and Competitors
Table 56. MGB Biopharma Limited Major Business
Table 57. MGB Biopharma Limited Vancomycin Product and Services
Table 58. MGB Biopharma Limited Vancomycin Sales (KG), Price (US$/G), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 59. Microbiotix. Basic Information, Manufacturing Base and Competitors
Table 60. Microbiotix. Major Business
Table 61. Microbiotix. Vancomycin Product and Services
Table 62. Microbiotix. Vancomycin Sales (KG), Price (US$/G), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 63. MicuRx Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 64. MicuRx Pharmaceuticals Major Business
Table 65. MicuRx Pharmaceuticals Vancomycin Product and Services
Table 66. MicuRx Pharmaceuticals Vancomycin Sales (KG), Price (US$/G), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 67. Nabriva Therapeutics Basic Information, Manufacturing Base and Competitors
Table 68. Nabriva Therapeutics Major Business
Table 69. Nabriva Therapeutics Vancomycin Product and Services
Table 70. Nabriva Therapeutics Vancomycin Sales (KG), Price (US$/G), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 71. NovaBay Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 72. NovaBay Pharmaceuticals Major Business
Table 73. NovaBay Pharmaceuticals Vancomycin Product and Services
Table 74. NovaBay Pharmaceuticals Vancomycin Sales (KG), Price (US$/G), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 75. NovoBiotic Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 76. NovoBiotic Pharmaceuticals Major Business
Table 77. NovoBiotic Pharmaceuticals Vancomycin Product and Services
Table 78. NovoBiotic Pharmaceuticals Vancomycin Sales (KG), Price (US$/G), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 79. Oragenics Basic Information, Manufacturing Base and Competitors
Table 80. Oragenics Major Business
Table 81. Oragenics Vancomycin Product and Services
Table 82. Oragenics Vancomycin Sales (KG), Price (US$/G), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 83. Sealife Pharma Basic Information, Manufacturing Base and Competitors
Table 84. Sealife Pharma Major Business
Table 85. Sealife Pharma Vancomycin Product and Services
Table 86. Sealife Pharma Vancomycin Sales (KG), Price (US$/G), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 87. Taiwan Zhengde Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 88. Taiwan Zhengde Pharmaceutical Major Business
Table 89. Taiwan Zhengde Pharmaceutical Vancomycin Product and Services
Table 90. Taiwan Zhengde Pharmaceutical Vancomycin Sales (KG), Price (US$/G), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 91. Zhejiang Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 92. Zhejiang Pharmaceutical Major Business
Table 93. Zhejiang Pharmaceutical Vancomycin Product and Services
Table 94. Zhejiang Pharmaceutical Vancomycin Sales (KG), Price (US$/G), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 95. Zhejiang Haizheng Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 96. Zhejiang Haizheng Pharmaceutical Major Business
Table 97. Zhejiang Haizheng Pharmaceutical Vancomycin Product and Services
Table 98. Zhejiang Haizheng Pharmaceutical Vancomycin Sales (KG), Price (US$/G), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 99. North China Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 100. North China Pharmaceutical Major Business
Table 101. North China Pharmaceutical Vancomycin Product and Services
Table 102. North China Pharmaceutical Vancomycin Sales (KG), Price (US$/G), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 103. Shenwei Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 104. Shenwei Pharmaceutical Major Business
Table 105. Shenwei Pharmaceutical Vancomycin Product and Services
Table 106. Shenwei Pharmaceutical Vancomycin Sales (KG), Price (US$/G), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 107. Global Vancomycin Sales by Manufacturer (2019, 2020, 2021, and 2022) & (KG)
Table 108. Global Vancomycin Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 109. Market Position of Manufacturers in Vancomycin, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 110. Global Vancomycin Production Capacity by Company, (KG): 2020 VS 2021
Table 111. Head Office and Vancomycin Production Site of Key Manufacturer
Table 112. Vancomycin New Entrant and Capacity Expansion Plans
Table 113. Vancomycin Mergers & Acquisitions in the Past Five Years
Table 114. Global Vancomycin Sales by Region (2017-2022) & (KG)
Table 115. Global Vancomycin Sales by Region (2023-2028) & (KG)
Table 116. Global Vancomycin Revenue by Region (2017-2022) & (USD Million)
Table 117. Global Vancomycin Revenue by Region (2023-2028) & (USD Million)
Table 118. Global Vancomycin Sales by Type (2017-2022) & (KG)
Table 119. Global Vancomycin Sales by Type (2023-2028) & (KG)
Table 120. Global Vancomycin Revenue by Type (2017-2022) & (USD Million)
Table 121. Global Vancomycin Revenue by Type (2023-2028) & (USD Million)
Table 122. Global Vancomycin Price by Type (2017-2022) & (US$/G)
Table 123. Global Vancomycin Price by Type (2023-2028) & (US$/G)
Table 124. Global Vancomycin Sales by Application (2017-2022) & (KG)
Table 125. Global Vancomycin Sales by Application (2023-2028) & (KG)
Table 126. Global Vancomycin Revenue by Application (2017-2022) & (USD Million)
Table 127. Global Vancomycin Revenue by Application (2023-2028) & (USD Million)
Table 128. Global Vancomycin Price by Application (2017-2022) & (US$/G)
Table 129. Global Vancomycin Price by Application (2023-2028) & (US$/G)
Table 130. North America Vancomycin Sales by Country (2017-2022) & (KG)
Table 131. North America Vancomycin Sales by Country (2023-2028) & (KG)
Table 132. North America Vancomycin Revenue by Country (2017-2022) & (USD Million)
Table 133. North America Vancomycin Revenue by Country (2023-2028) & (USD Million)
Table 134. North America Vancomycin Sales by Type (2017-2022) & (KG)
Table 135. North America Vancomycin Sales by Type (2023-2028) & (KG)
Table 136. North America Vancomycin Sales by Application (2017-2022) & (KG)
Table 137. North America Vancomycin Sales by Application (2023-2028) & (KG)
Table 138. Europe Vancomycin Sales by Country (2017-2022) & (KG)
Table 139. Europe Vancomycin Sales by Country (2023-2028) & (KG)
Table 140. Europe Vancomycin Revenue by Country (2017-2022) & (USD Million)
Table 141. Europe Vancomycin Revenue by Country (2023-2028) & (USD Million)
Table 142. Europe Vancomycin Sales by Type (2017-2022) & (KG)
Table 143. Europe Vancomycin Sales by Type (2023-2028) & (KG)
Table 144. Europe Vancomycin Sales by Application (2017-2022) & (KG)
Table 145. Europe Vancomycin Sales by Application (2023-2028) & (KG)
Table 146. Asia-Pacific Vancomycin Sales by Region (2017-2022) & (KG)
Table 147. Asia-Pacific Vancomycin Sales by Region (2023-2028) & (KG)
Table 148. Asia-Pacific Vancomycin Revenue by Region (2017-2022) & (USD Million)
Table 149. Asia-Pacific Vancomycin Revenue by Region (2023-2028) & (USD Million)
Table 150. Asia-Pacific Vancomycin Sales by Type (2017-2022) & (KG)
Table 151. Asia-Pacific Vancomycin Sales by Type (2023-2028) & (KG)
Table 152. Asia-Pacific Vancomycin Sales by Application (2017-2022) & (KG)
Table 153. Asia-Pacific Vancomycin Sales by Application (2023-2028) & (KG)
Table 154. South America Vancomycin Sales by Country (2017-2022) & (KG)
Table 155. South America Vancomycin Sales by Country (2023-2028) & (KG)
Table 156. South America Vancomycin Revenue by Country (2017-2022) & (USD Million)
Table 157. South America Vancomycin Revenue by Country (2023-2028) & (USD Million)
Table 158. South America Vancomycin Sales by Type (2017-2022) & (KG)
Table 159. South America Vancomycin Sales by Type (2023-2028) & (KG)
Table 160. South America Vancomycin Sales by Application (2017-2022) & (KG)
Table 161. South America Vancomycin Sales by Application (2023-2028) & (KG)
Table 162. Middle East & Africa Vancomycin Sales by Region (2017-2022) & (KG)
Table 163. Middle East & Africa Vancomycin Sales by Region (2023-2028) & (KG)
Table 164. Middle East & Africa Vancomycin Revenue by Region (2017-2022) & (USD Million)
Table 165. Middle East & Africa Vancomycin Revenue by Region (2023-2028) & (USD Million)
Table 166. Middle East & Africa Vancomycin Sales by Type (2017-2022) & (KG)
Table 167. Middle East & Africa Vancomycin Sales by Type (2023-2028) & (KG)
Table 168. Middle East & Africa Vancomycin Sales by Application (2017-2022) & (KG)
Table 169. Middle East & Africa Vancomycin Sales by Application (2023-2028) & (KG)
Table 170. Vancomycin Raw Material
Table 171. Key Manufacturers of Vancomycin Raw Materials
Table 172. Direct Channel Pros & Cons
Table 173. Indirect Channel Pros & Cons
Table 174. Vancomycin Typical Distributors
Table 175. Vancomycin Typical Customers
List of Figures
Figure 1. Vancomycin Picture
Figure 2. Global Vancomycin Revenue Market Share by Type in 2021
Figure 3. Daptomycin
Figure 4. Linezolid
Figure 5. Quinupristin
Figure 6. Ampicillin
Figure 7. Chloramphenicol
Figure 8. Others
Figure 9. Global Vancomycin Revenue Market Share by Application in 2021
Figure 10. Sepsis
Figure 11. Lung Infection
Figure 12. Skin Soft Tissue Infection
Figure 13. Colitis & Intestinal Inflammation
Figure 14. To Prevent Infection
Figure 15. Global Vancomycin Revenue, (USD Million) & (KG): 2017 & 2021 & 2028
Figure 16. Global Vancomycin Revenue and Forecast (2017-2028) & (USD Million)
Figure 17. Global Vancomycin Sales (2017-2028) & (KG)
Figure 18. Global Vancomycin Price (2017-2028) & (US$/G)
Figure 19. Global Vancomycin Production Capacity (2017-2028) & (KG)
Figure 20. Global Vancomycin Production Capacity by Geographic Region: 2022 VS 2028
Figure 21. Vancomycin Market Drivers
Figure 22. Vancomycin Market Restraints
Figure 23. Vancomycin Market Trends
Figure 24. Global Vancomycin Sales Market Share by Manufacturer in 2021
Figure 25. Global Vancomycin Revenue Market Share by Manufacturer in 2021
Figure 26. Vancomycin Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 27. Top 3 Vancomycin Manufacturer (Revenue) Market Share in 2021
Figure 28. Top 6 Vancomycin Manufacturer (Revenue) Market Share in 2021
Figure 29. Global Vancomycin Sales Market Share by Region (2017-2028)
Figure 30. Global Vancomycin Revenue Market Share by Region (2017-2028)
Figure 31. North America Vancomycin Revenue (2017-2028) & (USD Million)
Figure 32. Europe Vancomycin Revenue (2017-2028) & (USD Million)
Figure 33. Asia-Pacific Vancomycin Revenue (2017-2028) & (USD Million)
Figure 34. South America Vancomycin Revenue (2017-2028) & (USD Million)
Figure 35. Middle East & Africa Vancomycin Revenue (2017-2028) & (USD Million)
Figure 36. Global Vancomycin Sales Market Share by Type (2017-2028)
Figure 37. Global Vancomycin Revenue Market Share by Type (2017-2028)
Figure 38. Global Vancomycin Price by Type (2017-2028) & (US$/G)
Figure 39. Global Vancomycin Sales Market Share by Application (2017-2028)
Figure 40. Global Vancomycin Revenue Market Share by Application (2017-2028)
Figure 41. Global Vancomycin Price by Application (2017-2028) & (US$/G)
Figure 42. North America Vancomycin Sales Market Share by Type (2017-2028)
Figure 43. North America Vancomycin Sales Market Share by Application (2017-2028)
Figure 44. North America Vancomycin Sales Market Share by Country (2017-2028)
Figure 45. North America Vancomycin Revenue Market Share by Country (2017-2028)
Figure 46. United States Vancomycin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. Canada Vancomycin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. Mexico Vancomycin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Europe Vancomycin Sales Market Share by Type (2017-2028)
Figure 50. Europe Vancomycin Sales Market Share by Application (2017-2028)
Figure 51. Europe Vancomycin Sales Market Share by Country (2017-2028)
Figure 52. Europe Vancomycin Revenue Market Share by Country (2017-2028)
Figure 53. Germany Vancomycin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. France Vancomycin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. United Kingdom Vancomycin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Russia Vancomycin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Italy Vancomycin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Asia-Pacific Vancomycin Sales Market Share by Region (2017-2028)
Figure 59. Asia-Pacific Vancomycin Sales Market Share by Application (2017-2028)
Figure 60. Asia-Pacific Vancomycin Sales Market Share by Region (2017-2028)
Figure 61. Asia-Pacific Vancomycin Revenue Market Share by Region (2017-2028)
Figure 62. China Vancomycin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Japan Vancomycin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Korea Vancomycin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. India Vancomycin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Southeast Asia Vancomycin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Australia Vancomycin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. South America Vancomycin Sales Market Share by Type (2017-2028)
Figure 69. South America Vancomycin Sales Market Share by Application (2017-2028)
Figure 70. South America Vancomycin Sales Market Share by Country (2017-2028)
Figure 71. South America Vancomycin Revenue Market Share by Country (2017-2028)
Figure 72. Brazil Vancomycin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Argentina Vancomycin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Middle East & Africa Vancomycin Sales Market Share by Type (2017-2028)
Figure 75. Middle East & Africa Vancomycin Sales Market Share by Application (2017-2028)
Figure 76. Middle East & Africa Vancomycin Sales Market Share by Region (2017-2028)
Figure 77. Middle East & Africa Vancomycin Revenue Market Share by Region (2017-2028)
Figure 78. Turkey Vancomycin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. Egypt Vancomycin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 80. Saudi Arabia Vancomycin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 81. South Africa Vancomycin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 82. Manufacturing Cost Structure Analysis of Vancomycin in 2021
Figure 83. Manufacturing Process Analysis of Vancomycin
Figure 84. Vancomycin Industrial Chain
Figure 85. Sales Channel: Direct Channel vs Indirect Channel
Figure 86. Methodology
Figure 87. Research Process and Data Source

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のバンコマイシン市場2022年：ダプトマイシン、リネゾリド、キヌプリスチン、アンピシリン、クロラムフェニコール、その他(Global Vancomycin Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

世界のバンコマイシン市場2022年：ダプトマイシン、リネゾリド、キヌプリスチン、アンピシリン、クロラムフェニコール、その他

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp